Save $200 before early-bird expires
2019 Event Sponsors
Quay Pharmaceuticals is experienced in providing a comprehensive out-sourcing service to biotechnology and pharmaceutical companies for formulation and analytical development with subsequent clinical trial and commercial drug product manufacturing. We’re expertly skilled in dosage form design and development with a speciality in formulating APIs with poor solubility and bioavailability along with drug products requiring enteric delivery. Quay Pharma is also uniquely placed to support live biotherapeutic drug development.
Our technical team will underpin projects all the way from early pre-clinical formulation optimisation through to commercial manufacture, providing a bespoke and tailored service at every step.
Visit www.quaypharma.com to learn more about our MHRA and FDA inspected facilities and range of expertise.
Starpharma’s novel dendrimer-based DEP® platform has broad commercial applicability in drug delivery by enhancing the therapeutic utility of drugs through improved solubility, efficacy and pharmacokinetics, reductions in certain toxicities (e.g. bone marrow toxicity) and creating a unique intellectual property position. The novel DEP® platform has shown reproducible advantages across a wide range of drug classes and can be utilised with both small molecule drugs, peptides and proteins.
Starpharma uses DEP® both in its own drug development pipeline and with partners. The most advanced DEP® product in Starpharma’s pipeline is DEP® docetaxel which is in Phase 2 clinical trials. Positive interim trial results continue to show a notable lack of bone marrow toxicity and encouraging efficacy signals, including stable disease and tumour shrinkage. A second clinical candidate, DEP® cabazitaxel, is in adaptive phase 1 / 2 trial design, which enables a seamless transition from phase 1 to phase 2, to explore efficacy as early as possible. Starpharma’s third candidate, DEP® irinotecan, is expected to enter the clinic mid-year.
Starpharma is actively seeking partners for its DEP® drug delivery platform, and to combine partners’ proprietary oncology agents with DEP® therapeutics.
Visit us at: www.starpharma.com
Lipoid offers all types of lecithin and phospholipids which are excellent excipients for parenteral, pulmonary, dermal, and oral applications. Lipoid is set apart by our ability to manufacture all of our products under strict cGMP conditions on an industrial scale.
We supply natural, hydrogenated, and synthetic phospholipids for a host of formulation types, including emulsions, liposomes, mixed micelles, SEEDS, and solid lipid nanoparticles. All products are derived from highly controlled natural sources such as egg, soybean and sunflower. Our products meet the highest standards and all relevant regulations of the pharmaceutical industry.
Visit us at: www.lipoid.com
Wyatt Technology is the recognized leader in light scattering instrumentation for characterizing macromolecules and nanoparticles in solution. Wyatt’s products determine absolute molar mass, size, charge, interaction properties, conformation and conjugation. The company offers a complete suite of multi-angle light scattering (MALS) instruments, field-flow fractionation (FFF) systems, dynamic light scattering (DLS) and zeta potential instruments and detectors to measure refractive index and intrinsic viscosity.
Visit us at: www.wyatt.com
Glatt is a market leader in life science systems for the refinement and processing of powders. With the introduction of our new Advanced Pulse Powder technology – or APPtec® for short – we have expanded our expertise since 2015 to include innovative particle design through powder synthesis as an upstream process. As a result, we are now able to offer you integrated solutions throughout the entire value chain – from primary particle manufacturing to refining, and right up to finished tablets. With 14 branches and subsidiaries worldwide, we support customers in pharmaceuticals, food and feed processing and fine chemicals through our innovative process solutions. Do you have a product idea? We can assist you along the entire process chain. From the development of the process to the construction of your entire plant.
Visit us at: www.glatt.com
Fuji is a wholly owned subsidiary of Fuji Chemical Industries Co., Ltd. of Toyama, Japan. Fuji Chemical, founded in 1946, is a leading contract manufacturer with cGMP facilities for production of API, Spray Drying (including High Potent compounds) and finished dosage forms. Over the years, Fuji Chemical developed a unique and proprietary technology for powdering through Fuji’s spray drying expertise which led to the development of excipients with extraordinary properties. These high-performance excipients, Fujicalin®, Neusilin® , F-MELT® and Fujisil are being offered by Fuji Chemical Industries USA to our customers.
Through this technology, Fuji Chemical can offer speciality, high-performance excipients worldwide. These excipients have helped our customers overcome challenges in different aspects during the product development and formulation stages.
Visit us at: www.fujichemicalusa.com
Established in 2005, Dolomite Microfluidics has grown to be the industry leader in the design and manufacture of high quality innovative microfluidic products.
The company offers a range of microfluidic systems, modules and components – including pumps, chips, connectors, temperature controllers, sensors, accessories and custom-made components – as well as software for analysis or automation.
Modularity, ease of use, innovation and scalability are common to all Dolomite products, which are used across a broad range of applications in biology, drug discovery, chemistry, food, cosmetics and academia.
Dolomite is a part of the Blacktrace group of companies, a world leader in Productizing Science®, and has offices in the USA, Japan, India, Hanoi and Brazil, as well as a worldwide network of distributors.
Visit us at: http://www.dolomite-microfluidics.com
BioDuro is a full-service provider for integrated drug discovery and development, including discovery support, API synthesis and optimization, formulation development and cGMP manufacture of drug products. From drug substance to drug product, discovery to development, small molecule or biologics, BioDuro is your partner for accelerating drug discovery and development and improving efficiency in establishing drug candidate success.
BioDuro provides integrated drug development services from preformulation to clinical trial material (CTM) manufacturing. Our formulation services cover delivery systems and formulation technologies from simple API-in-capsule to enabled, solubilizing formulations utilizing approaches such as hot-melt extrusion and spray-dried dispersion. Our analytical expertise drives sound formulation and process development decisions. We provide phase-appropriate method development, validation, in-process, release and stability testing. BioDuro provides GMP-compliant manufacturing for solids, liquids and semi-solids, up to Phase III.
Visit us at: www.bioduro.com
MUNIT is a consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership in the micronization sector.
MUNIT is your access point to JETPHARMAs and MICROCHEMs services:
- Jet- , Pin- and Hammer milling
- Cryogenic Micronization
- Co- micronization
- Sieving, Blending, De-Lumping
- Technical trials, DoE Studies, Process development and validation
- PSD analysis etc.
The triangular company structure with its back-up potential, its technology transfer and the resulting flexibility is one of our unique features in the market and an important part of customers Business continuity plan.
With MUNITs lean organization, its welcoming and customer orientated attitude, we are able to guarantee best service, high efficiency and punctuality to our customers worldwide.
Visit us at www.munit.com
Lifecore Biomedical, LLC, is a leader in cGMP-compliant aseptic filling and manufacturing development of difficult to fill, high viscosity pharmaceuticals. Lifecore supports the clinical development and commercialization efforts of its partners by providing customized formulation, filling, and packaging services for pre-clinical development to commercial production.
Visit us at: www.lifecore.com
Foster Delivery Science focuses solely on Hot Melt Extrusion to blend client’s API’s into polymers for the purpose of enhancing solubility and bioavailability, or creating local delivery solutions. For over 10 years, Foster has provided clients formulation development, scale-up, clinical trial material and has expanded into a new 32,000 square foot GMP facility producing oral formulations, implants, films, and single strand fibers. We can offer our expertise to create co-extrusions where more than one release rate is required, or blending more than one API into a single formulation. Our facilities are located in Putnam, CT, just west of Boston for a short 75 minute drive.
Visit us at: www.deliveryscience.com
Pion offers a range of instruments and analytical services that improve lead generation, optimization, and selection. All our solutions include API-sparing techniques designed to measure and predict the critical physicochemical properties of target molecules. When data matters we apply out of the box problem-solving abilities and are committed to ensuring you reach a confident conclusion on your drug characterization problems
Visit us at: www.pion-inc.com
Currently, there is ONE remaining exhibit space available. Contact Mark Coulter at +1 (646) 604-2821 or email@example.com for further information.